Want to join the conversation?
$AGN, which competes with $MYL and $AMGN, said that for 2016, it expects to launch a multi-dose preservative free formulation of RESTASIS, a new botox indication; ACZONE 7.5%; XEN Stent for glaucoma; Oculeve for dry eye. The company has more than 70 projects in mid-to-late stage development and has multiple programs in each therapeutic areas.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.